https://www.medpagetoday.com/meetingcoverage/idweek/101364
0
0
29 words
0
Comments
ACTIV-6 trial shows no time-to-recovery benefit with anti-parasitic in mild-to-moderate disease
You are the first to view
Create an account or login to join the discussion